Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

NCT00839982 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fred Hutchinson Cancer Center

Collaborators